11.9 C
New York
Tuesday, November 17, 2026

Ozempic and Wegovy Users Fuel $74 Billion Supplement Boom as Doctors Raise Safety Concerns

Must read

NEW YORK, United States — Americans taking Ozempic and Wegovy are increasingly using dietary supplements to manage side effects, prompting concerns among medical experts about the safety and regulation of the products.

A Reuters investigation published on Tuesday, October 20, 2026, found that patients experiencing nausea, constipation, fatigue, and other symptoms are spending considerable sums on vitamins, protein supplements, and other products promoted through social media.

The growing demand has attracted major retailers and supplement manufacturers, while federal regulators are considering changes to rules governing the industry’s products.

Unlike prescription medicines, dietary supplements generally do not require approval from the US Food and Drug Administration (FDA) before being marketed.

Doctors warn that this makes it difficult for consumers to determine whether particular products contain the ingredients advertised or carry risks that have not been adequately examined.

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. | REUTERS/Hollie Adams
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. | REUTERS/Hollie Adams

Millions of Americans Now Use GLP-1 Drugs

Medications such as Novo Nordisk’s Ozempic and Wegovy have transformed treatment for obesity and type 2 diabetes, with clinical evidence also demonstrating cardiovascular benefits.

The drugs belong to a class known as GLP-1 receptor agonists, which have become increasingly widely prescribed.

Research by JPMorgan estimates that approximately 10 million Americans used the medications in 2025. That number could reach 25 million by 2030, according to the bank’s projections.

However, some patients experience gastrointestinal symptoms and other difficulties while undergoing treatment.

A survey by Nutrition Business Journal found that nearly half of people using GLP-1 medications had begun taking additional vitamins or dietary supplements after starting treatment.

Products containing fibre, protein, and probiotics were particularly popular.

Boston Consulting Group also found in a consumer survey that GLP-1 users were spending approximately 20 per cent more on protein, fibre, and collagen than they had before beginning their medication.

The reported spending increases have created additional business opportunities for manufacturers and retailers.

gut health
Models in image | Photo Credit: Dreamstime

Patients Spend Hundreds of Dollars Managing Side Effects

Among those purchasing supplements is Allison Vecchio, 42, an emergency room nurse from Fort Pierce, Florida.

Vecchio told Reuters that treatment with GLP-1 medication had been accompanied by severe weakness, digestive problems, and brittle nails.

She said she subsequently began using fibre, collagen, and electrolyte supplements and experienced an improvement in her symptoms.

The products cost her between $200 and $300 each month.

Vecchio also promotes health products on TikTok, where she has approximately 25,000 followers.

She receives payments from three brands and participates in TikTok Shop’s HealthPro programme, which is restricted to licensed healthcare professionals.

Another user, Terri Hart, 52, of Pittsburg, Kansas, began taking GLP-1 medication in 2023.

Hart said she experienced constipation, nausea, and fatigue before incorporating magnesium, vitamin B12, electrolytes, and other supplements into her routine.

She spends approximately $110 monthly on the products, which are not covered by her insurance.

Hart, who has more than 12,000 TikTok followers, earns commissions by recommending products she says have helped her.

She acknowledged that she has no medical qualifications and said she advises her audience to consult doctors before following her recommendations.

The women’s accounts describe their personal experiences and do not establish that the supplements are clinically effective treatments for medication-related symptoms.

credit card in UAE, holiday season shopping

Supplement Sales Exceed $74 Billion

The broader American dietary supplement market recorded sales exceeding $74 billion in 2025, according to Nutrition Business Journal.

Sales increased by 7 per cent that year, following growth of 5 per cent in 2024.

Social commerce platforms have become an important distribution channel.

TikTok Shop generated more than $1 billion in US dietary supplement sales during 2025, representing approximately 5.4 per cent of online sales in the category.

Erika Craft, a data analyst at Nutrition Business Journal, said the popularity of GLP-1 medications was attracting additional customers to the supplement industry and encouraging existing customers to purchase more products.

Retailers have expanded their offerings in response.

Target has increased its range of dietary supplements, while The Vitamin Shoppe has reported double-digit growth in sales of fibre and creatine products this year.

Jack Gayton, the retailer’s senior vice-president of merchandising, identified both categories as popular among people using GLP-1 medications.

The industry’s expansion has also attracted investment.

Financial data provider PitchBook recorded 95 acquisitions and mergers in the global supplement sector during 2025, with a combined value of $16.9 billion.

That compared with 115 transactions worth $7.3 billion in 2024.

By October 6, 2026, there had been 68 transactions valued at $14.6 billion.

Among the corporate developments, Procter & Gamble is preparing to acquire supplement manufacturer Thorne.

Japan’s Kirin Holdings also announced plans in August to purchase Canadian supplement company Jamieson Wellness.

Jamieson’s American brand, youtheory, introduced a product targeting GLP-1 users in early 2025.

Selenium

Doctors Question Product Safety and Online Marketing

Medical professionals are concerned that commercial enthusiasm for supplements has outpaced the evidence supporting some products.

Jonathan Bonnet, a clinical associate professor at Stanford University and chief medical officer of the Ardmore Institute of Health in Oklahoma, questioned whether consumers could reliably establish the contents of the products they purchase.

“If you can’t know what you’re taking, it’s hard to know what risks you’re undergoing,” Bonnet told Reuters.

The FDA regulates dietary supplements differently from prescription medications, and manufacturers generally do not have to obtain the agency’s approval before selling them.

Some researchers have also called for stronger oversight of supplement advertising by social media personalities.

Rob Fried, chief executive of Niagen Bioscience, raised concerns about manufacturers using influencers to make promotional claims.

Fried said companies could employ large numbers of online promoters to help sell their products, regardless of whether the claims were adequately supported.

Niagen Bioscience reported sales of $129 million in 2025.

The growth of influencer marketing has also introduced financial relationships between supplement brands and individuals presenting their personal health experiences to online audiences.

weight loss injections, ozempic, Hollywood weight loss drugs

US Regulators Consider Stronger Oversight

The federal government is considering measures intended to strengthen supervision of dietary ingredients.

Health and Human Services Secretary Robert F. Kennedy Jr. has proposed changes affecting the regulatory treatment of ingredients used in food and supplement products.

The FDA has also issued new guidance this year addressing the information manufacturers should submit when seeking reviews of new dietary ingredients.

Under an existing regulatory pathway, companies can determine that certain ingredients are generally recognised as safe without notifying the FDA.

A proposed rule would eliminate that route as part of Kennedy’s broader plans for food ingredient regulation.

The proposals have divided supplement manufacturers.

Jacqueline Maslan, chief executive of Body of Work, a vitamin company targeting women under 40, supports stronger reviews before products enter the market.

Other industry representatives have raised concerns about the FDA’s capacity to process additional submissions.

The Council for Responsible Nutrition, a supplement industry association, warned that expanded reviews could produce delays lasting several months.

Colin Watts, chief executive of Thorne, also questioned whether the agency had sufficient personnel to examine new ingredients quickly enough.

In a statement to Reuters, a spokesperson for the Department of Health and Human Services said the FDA was reviewing ways to update its regulatory approach while preserving consumer choice.

The discussions come as manufacturers expand their offerings for GLP-1 users and more patients incorporate dietary supplements into their treatment routines.

More articles

- Advertisement -The Fast Track to Earning Income as a Publisher
- Advertisement -The Fast Track to Earning Income as a Publisher

Latest article